DDC commissions a detailed market research signing with Five Dimensions Consultancy office (5D) to survey the KSA pharmaceutical market followed by a consultancy contract for the pharmaceutical facility project.
DDC founders take the first step and commission KPMG to develop the business plan and financial feasibility studies for the proposed pharmaceutical manufacturing plant.
DDC founders take an important next step and invest in a key future element for the production facility - a dedicated distribution network. The Saudi Company for Equilibrium Development (SCED) became a purpose built partner in 2016.
DDC commissions BOSCH Integrated Solutions Pharma, Germany (Syntegon) to provide the conceptual & basic design for the initial Oral Solid Dosages Line One. DDC then signs with BOSCH | SYNTEGON for future facility expansion planning.
DDC signs with Engineering Consultancy Design Services (EGEC) for the facility detailed design.
DDC signs a 20-year leased land contract with the Saudi Industrial Property Authority (MODON) for the manufacturing facility.
DDC signs with the Saudi Industrial Development Fund (SIDF) which fully approved the project, investing government capital. The government business partnership with DDC begins the Phase-One production line.
DDC signs a technology transfer agreement with ZENVISION PHARMA (Contract Research & Development).
© Copyright 2024. DDC LLC All Rights Reserved.